AMD-Associated Genes Encoding Stress-Activated MAPK Pathway Constituents Are Identified by Interval-Based Enrichment Analysis
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
PURPOSE: To determine whether common DNA sequence variants within groups of genes encoding elements of stress-activated mitogen-activated protein kinase (MAPK) signaling pathways are, in aggregate, associated with advanced AMD (AAMD). METHODS: We used meta-regression and exact testing methods to identify AAMD-associated SNPs in 1177 people with AAMD and 1024 AMD-free elderly peers from 3 large-scale genotyping projects on the molecular genetics of AMD. SNPs spanning independent AAMD-associated genomic intervals were examined with a multi-locus-testing method (INRICH) for enrichment within five sets of genes encoding constituents of stress-activated MAPK signaling cascades. RESULTS: Four-of-five pathway gene sets showed enrichment with AAMD-associated SNPs; findings persisted after adjustment for multiple testing in two. Strongest enrichment signals (P = 0.006) existed in a c-Jun N-terminal kinase (JNK)/MAPK cascade (Science Signaling, STKE CMP_10827). In this pathway, seven independent AAMD-associated regions were resident in 6 of 25 genes examined. These included sequence variants in: 1) three MAP kinase kinase kinases (MAP3K4, MAP3K5, MAP3K9) that phosphorylate and activate the MAP kinase kinases MAP2K4 and MAP2K7 (molecules that phosphorylate threonine and tyrosine residues within the activation loop of JNK); 2) a target of MAP2K7 (JNK3A1) that activates complexes involved in transcriptional regulation of stress related genes influencing cell proliferation, apoptosis, motility, metabolism and DNA repair; and 3) NR2C2, a transcription factor activated by JNK1A1 (a drugable molecule influencing retinal cell viability in model systems). We also observed AAMD-related sequence variants resident in genes encoding PPP3CA (a drugable molecule that inactivates MAP3K5), and two genes (TGFB2, TGFBR2) encoding factors involved in MAPK sensing of growth factors/cytokines. CONCLUSIONS: Linkage disequilibrium (LD)-independent genomic enrichment analysis yielded associations of AAMD with aggregates of functionally related genes encoding constituents of the JNK MAPK signaling pathway. FDA-approved drugs now exist to target constituents of stress-activated MAPK pathways and may offer reasonable approaches to preventing or treating AAMD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Using bioinformatics and GWAS tools, several MAPK pathway genes, including the JNK signaling pathway, have been identified as targets for an increased risk of advanced AMD pathology [ 31 ]”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089 · cited 1×
“edu/purcell/plink/) [32] and SAS (version 9.”
Common polygenic variation contributes to risk of schizophrenia and bipolar disorder
The International Schizophrenia Consortium (2009) · Nature · doi:10.1038/nature08185 · Cited by 4,821 · cited 1×
“[7] Ward & Kellis [8] review works demonstrating the influence of common alleles contributing small, but meaningful effects in traits or disease risk [9] – as in the present work, loci associated with complex traits at P-values far below those considered significant on a genome-wide level have clustered across the gen…”
BackgroundCommon SNPs explain a large proportion of the heritability for human height
Yang, J., Benyamin, B., McEvoy, B. P., Gordon, S., Henders, A. K., Nyholt, D. R., Madden, P. A., Heath, A. C., Martin, N. G., Montgomery, G. W., et al. (2010) · Nature Genetics · doi:10.1038/ng.608 · Cited by 4,446 · cited 1×
“[10] The central premise here is that inference based on single loci may not elucidate important contributions of genetic variants both manifesting weak associations and the capacity to act together in”
BackgroundMitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases
Johnson, G. L., & Lapadat, R. (2002) · Science · doi:10.1126/science.1072682 · Cited by 4,295 · cited 1×
“[24] MAPK protein phosphatases act to dephosphorylate serine and threonine residues on MAPKs – causing a reversion of MAPKs to inactive states.”
Background(2013) · The Lancet · doi:10.1016/s0140-6736(12)62129-1 · Cited by 3,010 · cited 1×
“[11,12].”
Prevalence of Age-Related Macular Degeneration in the United States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.564 · Cited by 2,736
Causes and Prevalence of Visual Impairment Among Adults in the UnitedStates
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.477 · Cited by 2,616 · cited 1×
“residents are living with advanced age-related macular degeneration (AAMD) [1], the most common cause of vision loss in people of western European ancestry.”
BackgroundOxygen-induced retinopathy in the mouse.
Smith, L. E. H., Wesolowski, E., McLellan, A., Kostyk, S. K., D’Amato, R. J., Sullivan, R., & D'Amore, P. A. (1994) · PubMed · Cited by 1,627
p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases
Kumar, S., Boehm, J., & Lee, J. C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1177 · Cited by 1,197
Proteolytic Inactivation of MAP-Kinase-Kinase by Anthrax Lethal Factor
Duesbery, N. S., Webb, C. P., Leppla, S. H., Gordon, V. M., Klimpel, K. R., Copeland, T. D., Ahn, N. G., Oskarsson, M. K., Fukasawa, K., Paull, K. D., et al. (1998) · Science · doi:10.1126/science.280.5364.734 · Cited by 1,008 · cited 1×
“[15] Anathrax lethal toxin (LeTx) has a similar activity profile to PD98059 in cancer cell lines [37] and is known to inactivate MAPK signaling pathways by cleaving the amino termini of MAP2K1, MAP2K2, MAP2K3, MAP2K4, MAP2K6, and MAP2K7 (reviewed in ref [16]).”
BackgroundAge-related macular degeneration: etiology, pathogenesis, and therapeutic strategies
Ambati, J., Ambati, B. K., Yoo, S. H., Ianchulev, S., & Adamis, A. P. (2003) · Survey of Ophthalmology · doi:10.1016/s0039-6257(03)00030-4 · Cited by 959 · cited 1×
“[4–6] AMD is a common complex disease and its polygenic nature has been partially characterized from 19 strongly-associated (P#1610) loci in a multi-center study on over 77,000 people.”
BackgroundSeven new loci associated with age-related macular degeneration
The AMD Gene Consortium (2013) · Nature Genetics · doi:10.1038/ng.2578 · Cited by 788 · cited 2×
“Approximately 20 loci strongly associated with AMD (P-values #1610(28)) were recently reported in a multicenter study on over 77,000 people [7].”
BackgroundWebvision: The Organization of the Retina and Visual System
Kolb, H., Fernández, E., & Nelson, R. (1995) · Cited by 544
Gene Ontology Analysis of GWA Study Data Sets Provides Insights into the Biology of Bipolar Disorder
Holmans, P., Green, E. K., Pahwa, J. S., Ferreira, M. A. R., Purcell, S. M., Sklar, P., Owen, M. J., O'Donovan, M. C., & Craddock, N. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.05.011 · Cited by 378 · cited 1×
“significance threshold was chosen following to previous work [33] that retains the top 5% of genic intervals in the single-variant association tests.”
MethodAge‐related Macular Degeneration (AMD)
(2008) · Encyclopedia of Molecular Pharmacology · doi:10.1007/978-3-540-38918-7_5059 · Cited by 314
INRICH: interval-based enrichment analysis for genome-wide association studies
Lee, P. H., O'Dushlaine, C., Thomas, B., & Purcell, S. M. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts191 · Cited by 238 · cited 7×
“Using data from a whole genome genotyping microarray and a multi-locus enrichment analysis [11], we have identified AAMDassociated regions related to a ,30% change in the likelihood of having AAMD within 6-of-25 tested constituents of the stressactivated protein JNK MAPK signaling cascade (a pathway involved in cellul…”
MethodInfluentialSelf-citationVEGF polymorphisms are associated with neovascular age-related macular degeneration
Churchill, A. J. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl238 · Cited by 189 · cited 1×
“[21,22] AAMD-associated single nucleotide polymorphisms (SNPs) also exist in genes encoding cell surface and nuclear receptors known to act in MAPK pathways – such genes include the members of the: 1) peroxisome proliferator activator receptor (PPAR)/retinoid X receptor (RXR) complex [22]; 2) VEGF signaling system[22,…”
BackgroundPagès, G., Berra, E., Milanini, J., Levy, A. P., & Pouysségur, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002104200 · Cited by 184 · cited 1×
“[13] The same team reported that VEGF mRNA induction is inhibited by JNK blockade with the drug SB202190.”
BackgroundTherapeutic targets in age-related macular disease
Bird, A. C. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42437 · Cited by 175
Pathogenesis of retinopathy of prematurity
Smith, L. (2002) · Acta Paediatrica · doi:10.1111/j.1651-2227.2002.tb00157.x · Cited by 110 · cited 1×
“[34–36] VEGF activates MAPKs via insulin-like growth factor 1 (IGF1) and recent work on primary human RPE (hRPE) cells has demonstrated that constituents of MAPK pathways are likely to influence IGF1-mediated retinal angiogenesis.”
BackgroundHolmans, P. (2010) · Advances in genetics · doi:10.1016/b978-0-12-380862-2.00007-2 · Cited by 109 · cited 1×
“false-positive ones, which is unknown a-priori and specific to each phenotype [38].”
BackgroundGuma, M., Rius, J., Duong-Polk, K. X., Haddad, G. G., Lindsey, J. D., & Karin, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902659106 · Cited by 80 · cited 4×
“[14] This body of in vivo evidence guided our focus on stress-activated MAPK cascades.”
BackgroundMethodInfluentialPons, M., Cousins, S. W., Alcazar, O., Striker, G. E., & Marin‐Castaño, M. E. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.02.006 · Cited by 78
Du, H., Sun, X., Guma, M., Luo, J., Ouyang, H., Zhang, X., Zeng, J., Quach, J., Nguyen, D. H., Shaw, P. X., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221729110 · Cited by 74 · cited 3×
“[17] A number of model cell systems in immortalized RPE cells have implicated constituents of the JNK MAPK pathway in retinal cell survival.”
BackgroundGalan, A., Ferlin, A., Caretti, L., Buson, G., Sato, G., Frigo, A. C., & Foresta, C. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.01.030 · Cited by 67
Clinical implications of vascular growth factors in proliferative retinopathies
Aiello, L. P. (1997) · Current Opinion in Ophthalmology · doi:10.1097/00055735-199706000-00005 · Cited by 65 · cited 1×
“[34–36] VEGF activates MAPKs via insulin-like growth factor 1 (IGF1) and recent work on primary human RPE (hRPE) cells has demonstrated that constituents of MAPK pathways are likely to influence IGF1-mediated retinal angiogenesis.”
BackgroundJiang, Q. (2011) · Molecular Medicine Reports · doi:10.3892/mmr.2011.582 · Cited by 59 · cited 1×
“Findings from model systems investigating AMD-related pathophysiology [13–20] and our studies on the molecular genetics of AMD [21,22] led us to examine the putative role of stressactivated protein kinase (SAPK) signaling pathways in AMD pathogenesis.”
BackgroundMitogen-Activated Protein Kinases in Endothelial Pathophysiology
Bogatcheva, N. V., Dudek, S. M., Garcia, J. G. N., & Verin, A. D. (2003) · Journal of Investigative Medicine · doi:10.1136/jim-51-06-30 · Cited by 54 · cited 1×
“We reasoned that MAPKs and MAPK protein phosphatases of these pathways, their targeting enzymes, ligands, targets, and metabolites may form systems that influence AMD pathogenesis through regulation of aggregate transcriptional responses to chronic environmental and biochemical cellular stressors to which the retina i…”
BackgroundVascular endothelial growth factor gene regulation and action in diabetic retinopathy
LU, M., & ADAMIS, A. (2002) · Ophthalmology Clinics of North America · doi:10.1016/s0896-1549(01)00010-4 · Cited by 41 · cited 1×
“[34–36] VEGF activates MAPKs via insulin-like growth factor 1 (IGF1) and recent work on primary human RPE (hRPE) cells has demonstrated that constituents of MAPK pathways are likely to influence IGF1-mediated retinal angiogenesis.”
BackgroundSanGiovanni, J. P., Chen, J., Sapieha, P., Aderman, C. M., Stahl, A., Clemons, T. E., Chew, E. Y., & Smith, L. E. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053155 · Cited by 35
Self-citationChiu, C., Conley, Y. P., Gorin, M. B., Gensler, G. R., Lai, C., Fu, S., & Taylor, A. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-7782 · Cited by 33 · cited 1×
“[28].”
Xu, J., Zhu, D., He, S., Spee, C. K., Ryan, S. J., & Hinton, D. R. (2011) · The FASEB Journal · doi:10.1096/fj.10-178350 · Cited by 28 · cited 1×
“Findings from model systems investigating AMD-related pathophysiology [13–20] and our studies on the molecular genetics of AMD [21,22] led us to examine the putative role of stressactivated protein kinase (SAPK) signaling pathways in AMD pathogenesis.”
BackgroundWeng, C. Y., Kothary, P. C., Verkade, A. J., Reed, D. M., & Monte, M. A. D. (2009) · Current Eye Research · doi:10.3109/02713680903177890 · Cited by 27 · cited 2×
“[15] We observed AAMD associations with a number of SNPs in insulin signaling system genes.”
Backgroundde Almeida, L. N. F., Melilo-Carolino, R., Veloso, C. E. D. R., Pereira, P. A., de Miranda, D. M., Marco, L. A. D., & Nehemy, M. B. (2011) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-011-1807-5 · Cited by 21 · cited 1×
“[21,22] AAMD-associated single nucleotide polymorphisms (SNPs) also exist in genes encoding cell surface and nuclear receptors known to act in MAPK pathways – such genes include the members of the: 1) peroxisome proliferator activator receptor (PPAR)/retinoid X receptor (RXR) complex [22]; 2) VEGF signaling system[22,…”
BackgroundPerturbation of Mouse Retinal Vascular Morphogenesis by Anthrax Lethal Toxin
Bromberg-White, J. L., Boguslawski, E. A., & Duesbery, N. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006956 · Cited by 12 · cited 2×
“[16] used an in vivo murine model of retinal vascular development to examine the effects LeTx on nascent retinal vascular networks.”
BackgroundMethodInterpreting noncoding genetic variation in complex traits and human disease
Ward, L. D., & Kellis, M. (2012) · Nature Biotechnology · doi:10.1038/nbt.2422 · Cited by 6 · cited 1×
“[7] Ward & Kellis [8] review works demonstrating the influence of common alleles contributing small, but meaningful effects in traits or disease risk [9] – as in the present work, loci associated with complex traits at P-values far below those considered significant on a genome-wide level have clustered across the gen…”
BackgroundAdvanced AMD and Variants in Elements of Omega-3 Lipid-Associated Signaling Pathways
SanGiovanni, J. P., Clemons, T. E., Agrón, E., Vora, A., & Chew, E. Y. (2009) · Investigative Ophthalmology & Visual Science · Cited by 1
Self-citation
Research works printed but not linked: 1
- 38. Holmans P (2010) Statistical methods for pathway analysis of genome-wide data for association with complex genetic traits. Adv Genet 72: 141–179. · DOI
Cited by
Deep Learning of the Retina Enables Phenome- and Genome-Wide Analyses of the Microvasculature
Zekavat, S. M., Raghu, V. K., Trinder, M., Ye, Y., Koyama, S., Honigberg, M. C., Yu, Z., Pampana, A., Urbut, S., Haidermota, S., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.057709 · Cited by 176
Targeting MAPK Signaling in Age-Related Macular Degeneration
Kyosseva, S. V. (2016) · Ophthalmology and Eye Diseases · doi:10.4137/oed.s32200 · Cited by 74
MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges
Moustardas, P., Aberdam, D., & Lagali, N. (2023) · Cells · doi:10.3390/cells12040617 · Cited by 63
“Using bioinformatics and GWAS tools, several MAPK pathway genes, including the JNK signaling pathway, have been identified as targets for an increased risk of advanced AMD pathology [31] and the activation of ERKs has been associated in RPE-choroid AMD phenotypes [32].”
MethodSNP detection using RNA-sequences of candidate genes associated with puberty in cattle
Barbero, M. M. D., Cánovas, Á., Rojas, C. M., Riley, D. G., Luna‐Nevárez, P., Coleman, S. J., Speidel, S. E., Enns, R. M., Islas‐Trejo, A., Medrano, J. F. F., et al. (2017) · Genetics and Molecular Research · doi:10.4238/gmr16019522 · Cited by 61
Simón, M. V., Agnolazza, D. L., German, O. L., Garelli, A., Politi, L. E., Agbaga, M., Anderson, R. E., & Rotstein, N. P. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13487 · Cited by 53
Metadata
- Authors
- SanGiovanni, J. P., & Lee, P. H.
- Affiliations
- National Institutes of Health (US)
- Harvard University (US)
- Corresponding author
- SanGiovanni, John Paul
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-08-05
- Volume
- 8
- Issue
- 8
- Pages
- e71239
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3734129
- OpenAlex
- W2143136951
- Cited by
- 26
- References
- 37
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 1 · 2023: 5 · 2021: 1 · 2020: 3 · 2019: 1 · 2018: 1 · 2017: 3 · 2016: 3 · 2015: 2 · 2014: 2
- FWCI
- 2.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Eye Institute
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Keywords
- age-related macular degeneration, advanced AMD, JNK MAPK pathway, single nucleotide polymorphisms, MAP3K4, MAP3K5, MAP3K9, MAP2K4, MAP2K7, NR2C2, PPP3CA, transforming growth factor-beta2, TGFBR2, therapeutic target
- MeSH terms
- Aged, Aged, 80 and over, Cell Survival, Female, Genotype, Humans, Macular Degeneration, Male, Linkage Disequilibrium, Polymorphism, Single Nucleotide, MAP Kinase Signaling System, Intercellular Signaling Peptides and Proteins, JNK Mitogen-Activated Protein Kinases, p38 Mitogen-Activated Protein Kinases, Gene Regulatory Networks, Genome-Wide Association Study, High-Throughput Screening Assays
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.